Key points from article :
Immunai claims its platform can be used to more accurately monitor efficacy of immunotherapy.
"Our platform identifies common patterns not visible looking at narrower disease-specific view."
Uses single-cell technologies to extract data from blood samples.
Then uses machine learning algorithms to map data to cell types and create immune profiles.
The database of immune profiles supports biomarker discovery and insight generation.
This identifies subtle changes in cell type and state-specific expression.
GE Healthcare partnered with Vanderbilt University Medical Center last year.
This is to use AI to retroactively analyze data from anonymized patient records.
Creates new tools allowing clinicians to more accurately predict patients' response to therapy.
National University of Singapore unveiled a cancer "scorecard" or Tumor Matrisome Index.
Developed using big data, predictive analysis of more than 30,000 patient-derived biopsies.
